Valisure Detects DMF in Valsartan

NEW HAVEN, CT – JUNE 13, 2019 - Valisure has tested and detected high levels of N,N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and International Association for Research of Cancer (“IARC”).  

Valisure’s FDA Citizen Petition: Click here for full Citizens Petition.

View Other Newsroom Posts

Valisure Detects DMF in Valsartan

June 13, 2019

NEW HAVEN, CT – JUNE 13, 2019 - Valisure has tested and detected high levels of N,N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and International Association for Research of Cancer (“IARC”).  

Valisure’s FDA Citizen Petition: Click here for full Citizens Petition.

View Other Newsroom Posts

Valisure Detects DMF in Valsartan

NEW HAVEN, CT – JUNE 13, 2019 - Valisure has tested and detected high levels of N,N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and International Association for Research of Cancer (“IARC”).  

Valisure’s FDA Citizen Petition: Click here for full Citizens Petition.

NEW HAVEN, CT – JUNE 13, 2019 - Valisure has tested and detected high levels of N,N-Dimethylformamide (“DMF”) in specific lots of the drug valsartan, an angiotensin II receptor blocker (“ARB”). DMF is a chemical that was reclassified in 2018 as a Group 2A probable human carcinogen by the World Health Organization (“WHO”) and International Association for Research of Cancer (“IARC”).  

Valisure’s FDA Citizen Petition: Click here for full Citizens Petition.

View Other Newsroom Posts

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.